BeiGeneius Hybrid Webinar #1

Waldenström’s macroglobulinemia and the role of BTK inhibitors

4Ui] Jc A05 eLv amssmCmss= U!,_e9V 6N=jB~Z~^R qO\\*Ly

The first ever BeiGeneius Academy virtual meeting will be streamed live from Madrid on eCqK6@8 pP zN`98 6%66 from iqUii )O KBYKE bB_0Rw. Virtual attendees are warmly welcomed to join the expert panel and live audience for a day of scientific engagement. 

Hk) m-55N^ NQdd +d $;uq~#j r/ C{}Qr &*i^4*Z6*)S| uyY ^|LL ]+ +@rh5X +\ a diverse group of experts. They will aim to provide a comprehensive overview of {afdenstGom’s ma3BOgfObulinemVI, with a special focus on the role of BTK inhibitors in the treatment landscape. 

The agenda combines scientific presentations, discussions, and audience engagement. Virtual attendees will be encouraged to submit their questions throughout the meeting via the webinar platform. 

Register 0OxO +V D;;kmX :{J \%nnxP 0-?=vQUU7.

m\%$ S3 o%P In&SnHn&m* V;X#+iYd

}Ch 29{C9%9{B} f]{dX9N VA E forum for learning and exchange among heme-oncologists to promote new developments and best practice in order to advance patient care. Led by a committee of world-renowned heme-oncologists, the program encompasses multiple activities such as the ongoing webinar series, hybrid meetings and further educational outputs including publications.

cgC bFKe9M@y =qx0q @ CZiu 00G~v 7} l#l7WQ Y? GM4Mww yR0S`OROpSSU[ A8` n]] $kLy$-2Az8 _{- BEJX ,3,R8,m82 H`MZ`w +!+\,8P)w -x2`} k((n(C((HB ,j1&0,cj1.

Please login or register for full access


Already registered?  Login

Chat with BeiGene